AN2 Therapeutics, Inc. · NASDAQ:ANTX

Commodore Capital LP reported a 9.90% stake in AN2 Therapeutics, Inc. (Schedule 13G/A)

Event Sep 30, 2026 · Filed Nov 16, 2026

Commodore Capital LP reported a 9.90% stake in AN2 Therapeutics, Inc., 3,879,705 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).

Stake
9.90%
Shares
3,879,705
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Commodore Capital LP9.90%3,879,705
Commodore Capital Master LP9.90%3,879,705
Robert Egen Atkinson9.90%3,879,705
Michael Kramarz9.90%3,879,705

Source

Download original · View original at SEC

Related